Introduction: The COVID-19 pandemic has impaired the sleep-wakefulness cycle especially of healthcare professionals (HP). Sleep is affected by many factors and preventable risk factors protect HP from sleep disorders. To evaluate sleep quality and sleep disorders in HP working to gain insight risk factors and to raise awareness about working risk groups. Materıal and methods: The study population consisted of a total of 1190 HP employed at a hospital during the COVID-19 pandemic. From this population, a sample of 110 HP was selected based on reported only complaints of sleep. A sociodemographic data form and subjective sleep-wakefulness scales were applied. Sleep disorder was evaluated according to the ICSD-3.Results: Most of the participants were female. It was observed that 67.3%of the HP had disturbed sleep quality, and that nurses and medical secretaries had more complaints compared to doctors. Insomnia disorders was the most common disorder among the participants. Cases of insomnia disorders were found to be 15.477 times higher among those who had a history of mental disorders in their families, smoking was shown to have the most negative effect on biological rhythm, and married people experienced more sleepiness during the day.Conclusıons: During the COVID-19 pandemic, ancillary health staff is at greater risk of experiencing deterioration of sleep quality and insomnia disorders. Female, being married, cigarette smoking, and family history of psychiatric disorders were correlated with the development of sleep complaints.
The aim of this study was to determine the frequency of metabolic syndrome (MetS) in patients with schizophrenia and bipolar disorder (BD) receiving antipsychotic (AP) medications. Methods: A total of 207 patients with schizophrenia and BD, diagnosed according to the DSM-IV criteria and receiving a regular AP treatment, were followed up in the Community Mental Health Center. The MetS was diagnosed according to the diagnostic criteria of the International Diabetes Federation. Patients with MetS were compared to those without it in terms of sociodemographic and clinical characteristics, as well as the AP medications administered. Results: MetS was detected in 28.5% of patients. The most commonly identified clinical finding was a large waist circumference (61%). Of the clinical characteristics among the patients using AP, a large waist circumference and high blood glucose levels were found to be significantly different. MetS was found to be more common in patients with schizophrenia on AP who used the clozapine monotherapy (18.6%), and in patients with BD who used quetiapine (11.9%). Valproate was found to be more commonly used in patients with BD in whom MetS was detected. Conclusion: A large waist circumference and high blood glucose levels are the most important follow-up criteria.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.